论文部分内容阅读
目的评价莫沙必利联合黛力新治疗功能性消化不良(FD)的疗效。方法随机将68例确诊FD的患者分两组,对照组34例用莫沙必利5mg,tid;治疗组34例在上述基础上加用黛力新10.5mg,bid,分别于早上8点与下午4点分服。疗程均为4周。观察症状消失情况并做对比分析。结果治疗组总有效率(82.3%),对照组总有效率(52.9%),两者相比差异有显著性意义(P<0.05)治疗过程中未见明显不良反应。结论莫沙必利联用黛力新治疗FD疗效显著无明显不良反应。
Objective To evaluate the efficacy of mosapride and dextrine in the treatment of functional dyspepsia (FD). Methods A total of 68 patients with FD were randomly divided into two groups. 34 patients in the control group were treated with mosapride 5mg and tid, and 34 patients in the treatment group were treated with dextrose 10.5mg bid on the basis of the above. Service at 4 o’clock in the afternoon. The course of treatment is 4 weeks. Observe the disappearance of symptoms and do comparative analysis. Results The total effective rate (82.3%) in the treatment group and the total effective rate in the control group (52.9%) were significantly different (P <0.05). No obvious adverse reactions were observed during the treatment. Conclusion Mosapride combined with Deanxit treatment of FD significant no significant adverse reactions.